4//SEC Filing
IMMUNOGEN INC 4
Accession 0001104659-15-066207
CIK 0000855654operating
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 12:05 PM ET
Size
8.5 KB
Accession
0001104659-15-066207
Insider Transaction Report
Form 4
IMMUNOGEN INCIMGN
Johnston David Brannon
Chief Financial Officer
Transactions
- Exercise/Conversion
Common stock
2015-09-17$10.79/sh+5,000$53,950→ 5,000 total - Sale
Common stock
2015-09-17$15.00/sh−5,000$75,000→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2015-09-17$10.79/sh−5,000$53,950→ 90,000 totalExercise: $10.79From: 2015-07-17Exp: 2024-07-17→ Common stock (5,000 underlying)
Footnotes (3)
- [F1]Weighted average price of shares sold
- [F2]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on June 16, 2015.
- [F3]Exercisable as to 33,334 shares commencing on July 17, 2015, 33,333 shares commencing on July 17, 2016, and 33,333 shares commencing on July 17, 2017.
Documents
Issuer
IMMUNOGEN INC
CIK 0000855654
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000855654
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 12:05 PM ET
- Size
- 8.5 KB